SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-13-001660
Filing Date
2013-02-26
Accepted
2013-02-26 06:15:09
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2213006z10-k.htm 10-K 1694579
2 EX-21 a2213006zex-21.htm EX-21 3645
3 EX-23.1 a2213006zex-23_1.htm EX-23.1 5598
4 EX-31.1 a2213006zex-31_1.htm EX-31.1 8926
5 EX-31.2 a2213006zex-31_2.htm EX-31.2 8870
6 EX-32.1 a2213006zex-32_1.htm EX-32.1 5251
7 EX-32.2 a2213006zex-32_2.htm EX-32.2 5242
14 G585245.JPG g585245.jpg GRAPHIC 63584
  Complete submission text file 0001047469-13-001660.txt   13947939

Data Files

Seq Description Document Type Size
8 EX-101.INS uthr-20121231.xml EX-101.INS 1922729
9 EX-101.SCH uthr-20121231.xsd EX-101.SCH 111652
10 EX-101.CAL uthr-20121231_cal.xml EX-101.CAL 175373
11 EX-101.DEF uthr-20121231_def.xml EX-101.DEF 483945
12 EX-101.LAB uthr-20121231_lab.xml EX-101.LAB 1846018
13 EX-101.PRE uthr-20121231_pre.xml EX-101.PRE 835135
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26301 | Film No.: 13640947
SIC: 2834 Pharmaceutical Preparations